The Uromigos
Un pódcast de The Uromigos
401 Episodo
-
Episode 143: The Uromigos Paper of the Month - Determinants of anti- PD-1 response and resistance in clear cell renal cell carcinoma
Publicado: 17/11/2021 -
Episode 142: Un resumen de la reciente reunión de Uromigos en Canarias
Publicado: 13/11/2021 -
Episode 141: Movember - Past, Present and Future
Publicado: 5/11/2021 -
Episode 140: What is the role of ipilimumab in renal cancer?
Publicado: 29/10/2021 -
Episode 139: The Uromigos Paper of the Month - Talazoparib in biomarker positive prostate cancer
Publicado: 27/10/2021 -
Episode 138: Renal Cancer ESMO Guidelines Update
Publicado: 22/10/2021 -
Episode 137: ESMO 2021: PEACE1 overall survival in prostate cancer
Publicado: 19/9/2021 -
Episode 136: ESMO 2021: STAMPEDE Abiraterone for high-risk non-metastatic prostate cancer
Publicado: 19/9/2021 -
Episode 135: ESMO 2021: The STAR Study
Publicado: 19/9/2021 -
Episode 134: ESMO 2021: The PRISM Study
Publicado: 19/9/2021 -
Episode 133: ESMO 2021: Cabozantinib and atezolizumab in prostate cancer
Publicado: 18/9/2021 -
Episode 132: ESMO 2021: Pembro + sEphB4-HAS in bladder cancer
Publicado: 17/9/2021 -
Episode 131: ESMO 2021: The NORSE Study - Erdafitinib vs Erdafitinib/Cetrelimab
Publicado: 17/9/2021 -
Episode 130: Larry Einhorn - The Uromigos Legends in GU Cancer series
Publicado: 6/9/2021 -
Episode 129: Phil Kantoff - The Uromigos Legends in GU Cancer series
Publicado: 2/9/2021 -
Episode 128: APCCC - PSA relapse post prostatectomy
Publicado: 31/8/2021 -
Episode 127: APCCC - Adjuvant radiotherapy post prostatectomy
Publicado: 31/8/2021 -
Episode 126: APCCC - germ line testing and molecular testing in prostate cancer
Publicado: 31/8/2021 -
Episode 125: The Uromigos Paper of the Month - MRI screening for prostate cancer
Publicado: 27/8/2021 -
Episode 124: Dean Bajorin - The Uromigos Legends in GU Cancer series
Publicado: 23/8/2021
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
